Pathogens (Sep 2019)

Characterization and Protective Activity of Monoclonal Antibodies Directed against <i>Streptococcus suis</i> Serotype 2 Capsular Polysaccharide Obtained Using a Glycoconjugate

  • Guillaume Goyette-Desjardins,
  • Sonia Lacouture,
  • Jean-Philippe Auger,
  • René Roy,
  • Marcelo Gottschalk,
  • Mariela Segura

DOI
https://doi.org/10.3390/pathogens8030139
Journal volume & issue
Vol. 8, no. 3
p. 139

Abstract

Read online

Streptococcus suis serotype 2 is an encapsulated bacterium and an important swine pathogen. Opsonizing antibody responses targeting capsular polysaccharides (CPSs) are protective against extracellular pathogens. To elucidate the protective activity of monoclonal antibodies (mAbs) directed against S. suis serotype 2 CPS, mice were immunized with a serotype 2 CPS-glycoconjugate and three hybridomas were isolated; of which, two were murine IgMs and the other a murine IgG1. Whereas the IgMs (mAbs 9E7 and 13C8) showed different reactivity levels with S. suis serotypes 1, 1/2, 2 and 14, the IgG1 (mAb 16H11) was shown to be serotype 2-specific. All mAbs targeted the sialylated chain of the CPSs. Using an opsonophagocytosis assay, the IgMs were opsonizing towards the S. suis serotypes to which they cross-react, while the IgG1 failed to induce bacterial elimination. In a model of mouse passive immunization followed by a lethal challenge with S. suis serotype 2, the IgG1 and IgM cross-reacting only with serotype 14 (mAb 13C8) failed to protect, while the IgM cross-reacting with serotypes 1, 1/2, and 14 (mAb 9E7) was shown to be protective by limiting bacteremia. These new mAbs show promise as new S. suis diagnostic tools, as well as potential for therapeutic applications.

Keywords